Heron Therapeutics
HRTX
HRTX
162 hedge funds and large institutions have $163M invested in Heron Therapeutics in 2023 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 46 increasing their positions, 54 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
43% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 30
44% less capital invested
Capital invested by funds: $289M → $163M (-$126M)
73% less call options, than puts
Call options by funds: $20K | Put options by funds: $75K
Holders
162
Holding in Top 10
2
Calls
$20K
Puts
$75K
Top Buyers
| 1 | +$3.02M | |
| 2 | +$1.77M | |
| 3 | +$1.61M | |
| 4 |
Renaissance Technologies
New York
|
+$1.23M |
| 5 |
O
OrbiMed
New York
|
+$1.21M |
Top Sellers
| 1 | -$4.93M | |
| 2 | -$4.84M | |
| 3 | -$4.44M | |
| 4 |
Walleye Capital
New York
|
-$2.11M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$1.26M |